These mice recapitulate most of the metabolic manifestations in human lipodystrophy caused by SEIPIN loss-of-function mutations, such as a complete loss of functional WAT, early onset of hepatic steatosis, and insulin resistance (36). Here, BSCL2 is linked to Hepatic steatosis.